Mark Muthiah
Overview
Explore the profile of Mark Muthiah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
892
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Baral A, Garg S, Nguyen M, Razzaq R, Ang A, Khan H, et al.
Clin Gastroenterol Hepatol
. 2024 Jul;
22(12):2424-2431.e4.
PMID: 38969073
Background And Aims: Vibration-controlled transient elastography (VCTE) is used in clinical practice to risk-stratify liver transplant (LT) recipients; however, there are currently little data demonstrating the relationship between VCTE and...
12.
Fu C, Teng M, Tung D, Ramadoss V, Ong C, Koh B, et al.
Dig Dis Sci
. 2024 Jun;
69(9):3195-3205.
PMID: 38940975
Background: To overcome the limitations of the term "non-alcoholic fatty liver disease" (NAFLD), the term metabolic-associated steatotic liver disease (MASLD) was introduced. While epidemiologic studies have been conducted on MASLD,...
13.
Koh J, Chee D, Ng C, Wijarnpreecha K, Muthiah M, Tan D, et al.
Transplant Direct
. 2024 Jun;
10(7):e1642.
PMID: 38911272
Background: The cause of liver disease is changing, but its impact on liver transplantation (LT) for hepatocellular carcinoma (HCC) in women and men is unclear. We performed a nationwide study...
14.
Zhang S, Wang Q, Tan D, Sikka V, Ng C, Xian Y, et al.
J Extracell Vesicles
. 2024 Jun;
13(6):e12466.
PMID: 38887165
Food-derived extracellular vesicles (FEVs) are nanoscale membrane vesicles obtained from dietary materials such as breast milk, plants and probiotics. Distinct from other EVs, FEVs can survive the harsh degrading conditions...
15.
Kong G, Cao G, Koh J, Chan S, Zhang A, Wong E, et al.
Diabetes Obes Metab
. 2024 May;
26(8):3328-3338.
PMID: 38779875
Aim: Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) are at increased risk of incident cardiovascular disease. However, the clinical characteristics and prognostic importance of MASLD in patients presenting with...
16.
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon
Huang D, Shen L, Phyo W, Cloherty G, Butler E, Kuhns M, et al.
Antiviral Res
. 2024 Apr;
227:105876.
PMID: 38641023
Background: HBeAg loss is an important endpoint for antiviral therapy in chronic hepatitis B (CHB), however there are no reliable biomarkers to identify patients who will respond to the addition...
17.
Chew N, Pan X, Chong B, Chandramouli C, Muthiah M, Lam C
Diabetes Res Clin Pract
. 2024 Apr;
211:111652.
PMID: 38574897
The metabolic syndrome, characterized by type 2 diabetes mellitus (T2DM), hypertension, hyperlipidemia, and obesity, collectively increases the risk of cardiovascular diseases. Nonalcoholic fatty liver disease (NAFLD) is a prominent manifestation,...
18.
Arshad T, Vainer D, Khan H, Baral A, Garg S, Ang A, et al.
Dig Dis Sci
. 2024 Mar;
69(5):1844-1851.
PMID: 38499735
Introduction: Vibration-controlled transient elastography (VCTE) based liver stiffness measurement (LSM) is an excellent 'rule-out' test for advanced hepatic fibrosis in liver transplant (LT) recipients, however, its ability to 'rule-in' the...
19.
Aboona M, Faulkner C, Rangan P, Ng C, Huang D, Muthiah M, et al.
Liver Int
. 2024 Feb;
44(6):1316-1328.
PMID: 38407554
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease and 10%-20% occurs in lean individuals. There is little data in the literature regarding outcomes...
20.
Tan E, Huang D, Yee N, Wan Z, Nerurkar S, Kai J, et al.
Aliment Pharmacol Ther
. 2024 Feb;
59(8):984-992.
PMID: 38372477
Introduction: Given the global rise in obesity-related metabolic diseases, the upper limit of normal (ULN) alanine aminotransferase (ALT) in individuals with and without metabolic diseases may have changed. We performed...